Fish oil and rheumatoid arthritis: past, present and future

被引:59
|
作者
James, Michael [1 ]
Proudman, Susanna [1 ]
Cleland, Les [1 ]
机构
[1] Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA 5000, Australia
关键词
Rheumatoid arthritis; Fish oil; Pain; Non-steroidal anti-inflammatory drugs; POLYUNSATURATED FATTY-ACIDS; TUMOR-NECROSIS-FACTOR; CORONARY-HEART-DISEASE; DOUBLE-BLIND; OMEGA-3-FATTY-ACID SUPPLEMENTATION; ANTIINFLAMMATORY PROPERTIES; CONCOMITANT METHOTREXATE; DIETARY SUPPLEMENTATION; MONOCLONAL-ANTIBODY; PROSTAGLANDIN E-2;
D O I
10.1017/S0029665110001564
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Meta- and mega-analysis of randomised controlled trials indicate reduction in tender joint counts and decreased use of non-steroidal anti-inflammatory drugs with fish-oil supplementation in long-standing rheumatoid arthritis (RA). Since non-steroidal anti-inflammatory drugs confer cardiovascular risk and there is increased cardiovascular mortality in RA, an additional benefit of fish oil in RA may be reduced cardiovascular risk via direct mechanisms and decreased non-steroidal anti-inflammatory drug use. Potential mechanisms for anti-inflammatory effects of fish oil include inhibition of inflammatory mediators (eicosanoids and cytokines), and provision of substrates for synthesis of lipid suppressors of inflammation (resolvins). Future studies need progress in clinical trial design and need to shift from long-standing disease to examination of recent-onset RA. We are addressing these issues in a current randomised controlled trial of fish oil in recent-onset RA, where the aim is to intervene before joint damage has occurred. Unlike previous studies, the trial occurs on a background of drug regimens determined by an algorithm that is responsive to disease activity and drug intolerance. This allows drug use to be an outcome measure whereas in previous trial designs, clinical need to alter drug use was a 'problem'. Despite evidence for efficacy and plausible biological mechanisms, the limited clinical use of fish oil indicates there are barriers to its use. These probably include the pharmaceutical dominance of RA therapies and the perception that fish oil has relatively modest effects. However, when collateral benefits of fish oil are included within efficacy, the argument for its adjunctive use in RA is strong.
引用
收藏
页码:316 / 323
页数:8
相关论文
共 50 条
  • [1] Rheumatoid arthritis: past, present and future
    Bae, Sang-Cheol
    [J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2010, 53 (10): : 842 - 842
  • [2] Immunotherapy of rheumatoid arthritis: Past, present and future
    Sivakumar, B
    Paleolog, E
    [J]. CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (02) : 169 - 176
  • [3] Synovial Macrophages in Rheumatoid Arthritis: The Past, Present, and Future
    Tu, Jiajie
    Wang, Xinming
    Gong, Xun
    Hong, Wenming
    Han, Dafei
    Fang, Yilong
    Guo, Yawei
    Wei, Wei
    [J]. MEDIATORS OF INFLAMMATION, 2020, 2020
  • [4] Apoptosis and rheumatoid arthritis: Past, present, and future directions
    Mountz J.D.
    Hsu H.-C.
    Matsuki Y.
    Zhang H.-G.
    [J]. Current Rheumatology Reports, 2001, 3 (1) : 70 - 78
  • [5] Costs associated with rheumatoid arthritis in Italy: past, present, and future
    Benucci, Maurizio
    Rogai, Veronica
    Atzeni, Fabiola
    Hammen, Volker
    Sarzti-Puttini, Piercarlo
    Migliore, Alberto
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 33 - 41
  • [6] PHYSIOTHERAPY FOR RHEUMATOID ARTHRITIS (RA) - PAST, PRESENT AND A POSSIBLE FUTURE?
    Mengshoel, A. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1880 - 1880
  • [7] Rheumatoid arthritis: past, present and future approaches to treating the disease
    Hyndman, Iain J.
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (04) : 417 - 419
  • [8] Engineering nanoparticles for targeting rheumatoid arthritis: Past, present, and future trends
    Isabel Matos Oliveira
    Cristiana Gonçalves
    Rui Luís Reis
    Joaquim Miguel Oliveira
    [J]. Nano Research, 2018, 11 : 4489 - 4506
  • [9] Engineering nanoparticles for targeting rheumatoid arthritis: Past, present, and future trends
    Oliveira, Isabel Matos
    Goncalves, Cristiana
    Reis, Rui Luis
    Oliveira, Joaquim Miguel
    [J]. NANO RESEARCH, 2018, 11 (09) : 4489 - 4506
  • [10] Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans
    Barton, Pelham
    [J]. RHEUMATOLOGY, 2011, 50 : iv32 - iv38